Adição na publicação
#15.35
08/24/2021
RPI 2642
Application data
Number
112018013833Type
Filing
Publication
PCT
US2017012454 The application was abandoned: examination was not requested within the 36 months following the 01/06/2017 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 08/24/2021. We update with every new RPI gazette, published weekly.
Applicants
LA JOLLA PHARMACEUTICAL COMPANY
US
Inventors
G. T. (pessoa física)
US
L. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/276,727 · 01/08/2016
US
62/276,922 · 01/10/2016
US
62/287,285 · 01/26/2016
US
62/400,795 · 09/28/2016
US
62/436,070 · 12/19/2016
Abstract
A presente invenção se refere à utilização de hepcidina em métodos terapêuticos para o tratamento de várias condições nas quais pode ser benéfica a diminuição da concentração sérica de ferro.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
08/24/2021
RPI 2642
#11.1.1
06/30/2020
RPI 2582
#11.1
02/04/2020
RPI 2561
#1.3
12/11/2018
RPI 2501
#1.1
07/17/2018
RPI 2480
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.